These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25742225)
21. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer. Heijmen L; ter Voert EE; Oyen WJ; Punt CJ; van Spronsen DJ; Heerschap A; de Geus-Oei LF; van Laarhoven HW PLoS One; 2015; 10(4):e0120823. PubMed ID: 25831053 [TBL] [Abstract][Full Text] [Related]
22. Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT. Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC Cancer; 2015 Nov; 121(22):3965-74. PubMed ID: 26249241 [TBL] [Abstract][Full Text] [Related]
23. Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer. Rahman T; Tsujikawa T; Yamamoto M; Chino Y; Shinagawa A; Kurokawa T; Tsuchida T; Kimura H; Yoshida Y; Okazawa H Medicine (Baltimore); 2016 Mar; 95(9):e3017. PubMed ID: 26945427 [TBL] [Abstract][Full Text] [Related]
24. A pilot study for texture analysis of Nakajo M; Kajiya Y; Tani A; Jinguji M; Nakajo M; Kitazono M; Yoshiura T Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2158-2168. PubMed ID: 28770274 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
26. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer. Ulaner GA; Eaton A; Morris PG; Lilienstein J; Jhaveri K; Patil S; Fazio M; Larson S; Hudis CA; Jochelson MS Cancer Med; 2013 Oct; 2(5):725-33. PubMed ID: 24403238 [TBL] [Abstract][Full Text] [Related]
28. Predictive Value of Metabolic Parameters Derived From Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B Front Immunol; 2021; 12():724464. PubMed ID: 34512653 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [TBL] [Abstract][Full Text] [Related]
35. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma. Hwang SH; Lee JW; Cho HJ; Kim KS; Choi GH; Yun M Clin Nucl Med; 2017 Jan; 42(1):34-39. PubMed ID: 27775949 [TBL] [Abstract][Full Text] [Related]
37. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan. Goshen E; Davidson T; Zwas ST; Aderka D Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400 [TBL] [Abstract][Full Text] [Related]
38. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters. Chang S; Kim SJ Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846 [TBL] [Abstract][Full Text] [Related]
39. The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer. Soydal C; Kucuk ON; Gecim EI; Bilgic S; Elhan AH Nucl Med Commun; 2013 May; 34(5):501-6. PubMed ID: 23478586 [TBL] [Abstract][Full Text] [Related]
40. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis. Son SH; Lee SW; Jeong SY; Song BI; Chae YS; Ahn BC; Lee J AJR Am J Roentgenol; 2015 Oct; 205(4):878-85. PubMed ID: 26204115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]